Form N-2 - Registration statement for closed-end investment companies:
SEC Accession No. 0001193125-22-074437
Filing Date
2022-03-14
Accepted
2022-03-14 13:50:07
Documents
8

Document Format Files

Seq Description Document Type Size
1 BLACKROCK HEALTH SCIENCES TRUST d269284dn2.htm N-2 1794648
2 EX-FILING FEES d269284dexfilingfees.htm EX-FILING FEES 30784
4 GRAPHIC g269284g28z86.jpg GRAPHIC 6995
5 GRAPHIC g269284g32u14.jpg GRAPHIC 6671
6 GRAPHIC g269284g61y11.jpg GRAPHIC 6856
7 GRAPHIC g269284g68q68.jpg GRAPHIC 8320
8 GRAPHIC g269284g96p00.jpg GRAPHIC 34517
9 filename9.htm COVER 7417
  Complete submission text file 0001193125-22-074437.txt   1922451
Mailing Address 100 BELLEVUE PARKWAY WILMINGTON DE 19809
Business Address 100 BELLEVUE PARKWAY WILMINGTON DE 19809 (888) 825-2257
BlackRock Health Sciences Trust (Filer) CIK: 0001314966 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE
Type: N-2 | Act: 40 | File No.: 811-21702 | Film No.: 22736003

Mailing Address 100 BELLEVUE PARKWAY WILMINGTON DE 19809
Business Address 100 BELLEVUE PARKWAY WILMINGTON DE 19809 (888) 825-2257
BlackRock Health Sciences Trust (Filer) CIK: 0001314966 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE
Type: N-2 | Act: 33 | File No.: 333-263527 | Film No.: 22736002